Acasti Pharma Stock News

LAVAL, Quebec, March 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) today announces that it has appointed Michael L. Derby to its

LAVAL, Québec, March 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), announces the following patent notifications and awards rela

LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D’Alvise, President and Chief Exec

LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D’Alvise, President and Chief Executive Officer of Acasti Pharma will be presenting at the 32 nd Annual Oppenheimer Healthcare conference being held virtually March 15-17, 2022.

LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D'Alvise, President and Chief Executiv

CEO Jan D’Alvise participates in educational interviews regarding rare diseases, including subarachnoid hemorrhage, ataxia-telangiectasia and postherpetic neuralgia CEO Jan D’Alvise participates i

ARR, ACST, and ATUS have been added to the Zacks Rank #5 (Strong Sell) List on February 23, 2022

ARR, ACST, and ATUS have been added to the Zacks Rank #5 (Strong Sell) List on February 23, 2022

Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call Transcript

Acasti Pharma press release (ACST): Q4 GAAP EPS of -$0.09 misses by $0.01.Cash, cash equivalents and short-term investments totaled $46.3 million as of December 31, 2021, compared…

Provides updates on key milestones: GTX-104 PK study remains on track for results to be reported in the first half of calendar 2022; GTX-102 and GTX-101 progressing on schedule

Companies Reporting Before The Bell • Weber (NYSE: WEBR ) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million. • Kelly Services (NASDAQ: KELYB ) is expected to report earnings for its fourth quarter. • Westwater Resources (AMEX: WWR ) is likely to report earnings for its fourth quarter. • Scorpio Tankers (NYSE: STNG ) is expected to report quarterly loss at $0.75 per share on revenue of $151.10 million. • Kelly Services (NASDAQ: KELYA ) is expected to report quarterly earnings at $0.28 per share on revenue of $1.30 billion. • Garrett Motion (NASDAQ: GTX ) is projected to report quarterly earnings at $0.19 per share on revenue of $863.00 million. • Applied Genetic (NASDAQ: AGTC ) is expected to report earnings for its second quarter. • Alexander''s (NYSE: ALX ) is projected to report earnings for its fourth quarter. • Acasti Pharma (NASDAQ: ACST ) is estimated to report earnings for its third quarter. • Roivant Sciences (NASDAQ: ROIV ) is estimated to report earnings for its third quarter. • Olink Holding (NASDAQ: OLK ) is expected to report earnings for its fourth quarter. • Treehouse Foods (NYSE: THS ) is likely to report quarterly earnings at $0.09 per share on revenue of $1.12 billion. • Hawaiian Electric Indus (NYSE: HE ) is expected to report quarterly earnings at $0.42 per share on revenue of $681.34 million.

Call to be held on Monday, February 14th at 1:00 PM Eastern Time Call to be held on Monday, February 14th at 1:00 PM Eastern Time

Call to be held on Monday, February 14th at 1:00 PM Eastern Time Call to be held on Monday, February 14th at 1:00 PM Eastern Time